These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 30383799)

  • 1. Parahippocampal gyrus expression of endothelial and insulin receptor signaling pathway genes is modulated by Alzheimer's disease and normalized by treatment with anti-diabetic agents.
    Katsel P; Roussos P; Beeri MS; Gama-Sosa MA; Gandy S; Khan S; Haroutunian V
    PLoS One; 2018; 13(11):e0206547. PubMed ID: 30383799
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combination of Insulin with a GLP1 Agonist Is Associated with Better Memory and Normal Expression of Insulin Receptor Pathway Genes in a Mouse Model of Alzheimer's Disease.
    Robinson A; Lubitz I; Atrakchi-Baranes D; Licht-Murava A; Katsel P; Leroith D; Liraz-Zaltsman S; Haroutunian V; Beeri MS
    J Mol Neurosci; 2019 Apr; 67(4):504-510. PubMed ID: 30635783
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antidiabetic Polypill Improves Central Pathology and Cognitive Impairment in a Mixed Model of Alzheimer's Disease and Type 2 Diabetes.
    Infante-Garcia C; Ramos-Rodriguez JJ; Hierro-Bujalance C; Ortegon E; Pickett E; Jackson R; Hernandez-Pacho F; Spires-Jones T; Garcia-Alloza M
    Mol Neurobiol; 2018 Jul; 55(7):6130-6144. PubMed ID: 29224179
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ameliorating effect of anti-Alzheimer's drugs on the bidirectional association between type 2 diabetes mellitus and Alzheimer's disease.
    Ahmed AS; Elgharabawy RM; Al-Najjar AH
    Exp Biol Med (Maywood); 2017 Jul; 242(13):1335-1344. PubMed ID: 28534431
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antidiabetic drugs and their potential role in treating mild cognitive impairment and Alzheimer's disease.
    Alagiakrishnan K; Sankaralingam S; Ghosh M; Mereu L; Senior P
    Discov Med; 2013 Dec; 16(90):277-86. PubMed ID: 24333407
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vivo parahippocampal white matter pathology as a biomarker of disease progression to Alzheimer's disease.
    Solodkin A; Chen EE; Van Hoesen GW; Heimer L; Shereen A; Kruggel F; Mastrianni J
    J Comp Neurol; 2013 Dec; 521(18):4300-17. PubMed ID: 23839862
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impacts of CD33 Genetic Variations on the Atrophy Rates of Hippocampus and Parahippocampal Gyrus in Normal Aging and Mild Cognitive Impairment.
    Wang WY; Liu Y; Wang HF; Tan L; Sun FR; Tan MS; Tan CC; Jiang T; Tan L; Yu JT;
    Mol Neurobiol; 2017 Mar; 54(2):1111-1118. PubMed ID: 26803496
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New views and possibilities of antidiabetic drugs in treating and/or preventing mild cognitive impairment and Alzheimer's Disease.
    Zhong KL; Chen F; Hong H; Ke X; Lv YG; Tang SS; Zhu YB
    Metab Brain Dis; 2018 Aug; 33(4):1009-1018. PubMed ID: 29626315
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Middle-Aged Diabetic Females and Males Present Distinct Susceptibility to Alzheimer Disease-like Pathology.
    Candeias E; Duarte AI; Sebastião I; Fernandes MA; Plácido AI; Carvalho C; Correia S; Santos RX; Seiça R; Santos MS; Oliveira CR; Moreira PI
    Mol Neurobiol; 2017 Oct; 54(8):6471-6489. PubMed ID: 27730513
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of pituitary adenylate cyclase-activating polypeptide with cognitive decline in mild cognitive impairment due to Alzheimer disease.
    Han P; Caselli RJ; Baxter L; Serrano G; Yin J; Beach TG; Reiman EM; Shi J
    JAMA Neurol; 2015 Mar; 72(3):333-9. PubMed ID: 25599520
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Global changes in DNA methylation and hydroxymethylation in Alzheimer's disease human brain.
    Coppieters N; Dieriks BV; Lill C; Faull RL; Curtis MA; Dragunow M
    Neurobiol Aging; 2014 Jun; 35(6):1334-44. PubMed ID: 24387984
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insulin uptake and action in microvascular endothelial cells of lymphatic and blood origin.
    Jaldin-Fincati JR; Pereira RVS; Bilan PJ; Klip A
    Am J Physiol Endocrinol Metab; 2018 Aug; 315(2):E204-E217. PubMed ID: 29509435
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microvascular changes in Down syndrome with Alzheimer's-type pathology: Insights into a potential vascular mechanism for Down syndrome and Alzheimer's disease.
    Drachman DA; Smith TW; Alkamachi B; Kane K
    Alzheimers Dement; 2017 Dec; 13(12):1389-1396. PubMed ID: 28627379
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antidiabetic Drugs in Alzheimer's Disease and Mild Cognitive Impairment: A Systematic Review.
    Muñoz-Jiménez M; Zaarkti A; García-Arnés JA; García-Casares N
    Dement Geriatr Cogn Disord; 2020; 49(5):423-434. PubMed ID: 33080602
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The prediction of rapid conversion to Alzheimer's disease in mild cognitive impairment using regional cerebral blood flow SPECT.
    Hirao K; Ohnishi T; Hirata Y; Yamashita F; Mori T; Moriguchi Y; Matsuda H; Nemoto K; Imabayashi E; Yamada M; Iwamoto T; Arima K; Asada T
    Neuroimage; 2005 Dec; 28(4):1014-21. PubMed ID: 16129627
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Volumetric MRI measurements can differentiate Alzheimer's disease, mild cognitive impairment, and normal aging.
    Bottino CM; Castro CC; Gomes RL; Buchpiguel CA; Marchetti RL; Neto MR
    Int Psychogeriatr; 2002 Mar; 14(1):59-72. PubMed ID: 12094908
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of rosiglitazone on LRP1 expression and amyloid β uptake in human brain microvascular endothelial cells: a possible role of a low-dose thiazolidinedione for dementia treatment.
    Moon JH; Kim HJ; Yang AH; Kim HM; Lee BW; Kang ES; Lee HC; Cha BS
    Int J Neuropsychopharmacol; 2012 Feb; 15(1):135-42. PubMed ID: 22040807
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Link between Type 2 Diabetes and Neurodegeneration: Roles for Amyloid-β, Amylin, and Tau Proteins.
    Bharadwaj P; Wijesekara N; Liyanapathirana M; Newsholme P; Ittner L; Fraser P; Verdile G
    J Alzheimers Dis; 2017; 59(2):421-432. PubMed ID: 28269785
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The presubiculum is preserved from neurodegenerative changes in Alzheimer's disease.
    Murray CE; Gami-Patel P; Gkanatsiou E; Brinkmalm G; Portelius E; Wirths O; Heywood W; Blennow K; Ghiso J; Holton JL; Mills K; Zetterberg H; Revesz T; Lashley T
    Acta Neuropathol Commun; 2018 Jul; 6(1):62. PubMed ID: 30029687
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The diabetes drug liraglutide reverses cognitive impairment in mice and attenuates insulin receptor and synaptic pathology in a non-human primate model of Alzheimer's disease.
    Batista AF; Forny-Germano L; Clarke JR; Lyra E Silva NM; Brito-Moreira J; Boehnke SE; Winterborn A; Coe BC; Lablans A; Vital JF; Marques SA; Martinez AM; Gralle M; Holscher C; Klein WL; Houzel JC; Ferreira ST; Munoz DP; De Felice FG
    J Pathol; 2018 May; 245(1):85-100. PubMed ID: 29435980
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.